SciSparc Ltd. (NASDAQ:SPRC – Get Free Report)’s share price fell 1% on Tuesday . The company traded as low as $0.47 and last traded at $0.49. 2,290,869 shares were traded during trading, a decline of 72% from the average session volume of 8,072,014 shares. The stock had previously closed at $0.50.
SciSparc Price Performance
The company has a fifty day moving average price of $0.50 and a 200-day moving average price of $0.35.
SciSparc Company Profile
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
See Also
- Five stocks we like better than SciSparc
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Financial Services Stocks Investing
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- What is MarketRank™? How to Use it
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
